The Role of Glutamate and Blood-Brain Barrier Disruption as a Mechanistic Link between Epilepsy and Depression

被引:1
作者
Gruenbaum, Benjamin F. [1 ]
Schonwald, Antonia [2 ]
Boyko, Matthew [3 ]
Zlotnik, Alexander [3 ]
机构
[1] Mayo Clin, Dept Anesthesiol & Perioperat Med, Jacksonville, FL 32224 USA
[2] New York Med Coll, Valhalla, NY 10595 USA
[3] Ben Gurion Univ Negev, Soroka Univ, Dept Anesthesiol & Crit Care, Med Ctr, IL-84101 Beer Sheva, Israel
关键词
blood-brain barrier; depression; epilepsy; glutamate; neurodegeneration; STATUS EPILEPTICUS; NMDA RECEPTORS; CELL-DEATH; ANXIETY; TRANSFORMATION; COMORBIDITIES; METAANALYSIS; TRAFFICKING; NEURONS; GRIN2A;
D O I
10.3390/cells13141228
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Epilepsy is associated with substantial neuropsychiatric impairments that persist long after the onset of the condition, significantly impacting quality of life. The goal of this review was to uncover how the pathological consequences of epilepsy, such as excessive glutamate release and a disrupted blood-brain barrier (BBB), contribute to the emergence of neuropsychiatric disorders. We hypothesize that epilepsy induces a dysfunctional BBB through hyperexcitation, which then further amplifies post-ictal glutamate levels and, thus, triggers neurodegenerative and neuropsychiatric processes. This review identifies the determinants of glutamate concentration levels in the brain and explores potential therapeutic interventions that restore BBB integrity. Our focus on therapeutic BBB restoration is guided by the premise that it may improve glutamate regulation, consequently mitigating the neurotoxicity that contributes to the onset of neuropsychiatric symptoms.
引用
收藏
页数:10
相关论文
共 74 条
  • [1] Alahmari Abeer, 2021, Neural Plast, V2021, P6564585, DOI 10.1155/2021/6564585
  • [2] Glutamate and anxiety disorders
    Amiel J.M.
    Mathew S.J.
    [J]. Current Psychiatry Reports, 2007, 9 (4) : 278 - 283
  • [3] Regulation of AMPA receptor trafficking and synaptic plasticity
    Anggono, Victor
    Huganir, Richard L.
    [J]. CURRENT OPINION IN NEUROBIOLOGY, 2012, 22 (03) : 461 - 469
  • [4] Aronica EM, 1997, J NEUROSCI, V17, P8588
  • [5] Cortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy - Part 1
    Badawy, Radwa A. B.
    Harvey, Anthony S.
    Macdonell, Richard A. L.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (03) : 355 - 365
  • [6] Efficacy of treatments for anxiety disorders: a meta-analysis
    Bandelow, Borwin
    Reitt, Markus
    Roever, Christian
    Michaelis, Sophie
    Goerlich, Yvonne
    Wedekind, Dirk
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (04) : 183 - 192
  • [7] Glutamatergic Mechanisms Associated with Seizures and Epilepsy
    Barker-Haliski, Melissa
    White, H. Steve
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2015, 5 (08): : 1 - 15
  • [8] Psychiatric and behavioral comorbidities in epilepsy: A critical reappraisal
    Berg, Anne T.
    Altalib, Hamada H.
    Devinsky, Orrin
    [J]. EPILEPSIA, 2017, 58 (07) : 1123 - 1130
  • [9] Glutamate and anxiety
    Bergink, V
    van Megen, HJGM
    Westenberg, HGM
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (03) : 175 - 183
  • [10] Blood-Brain Barrier-Associated Proteins Are Elevated in Serum of Epilepsy Patients
    Bronisz, Elzbieta
    Cudna, Agnieszka
    Wierzbicka, Aleksandra
    Kurkowska-Jastrzebska, Iwona
    [J]. CELLS, 2023, 12 (03)